Bullboard - Stock Discussion Forum CNS Pharmaceuticals Inc CNSP

Healthcare

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for... see more

Add To Watchlist

NDAQ:CNSP - Post Discussion

CNS Pharmaceuticals Inc > Look at this!

View:

Post by Blocky on Jan 10, 2021 10:36am

Look at this!

Results coming soon!?

"WPD Pharmaceuticals is pleased to announce that in collaboration with CNS Pharmaceuticals it has identified several leading medical institutions in Poland to conduct its Berubicin Phase 2 clinical trial in adults with glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer.

The US Phase 2 trial Sponsor will be CNS and the Polish Phase 2 trial Sponsor will be WPD, a Polish corporation founded by Professor Waldemar Priebe, founder of both WPD and CNS. The Company expects to initiate both its Phase 2 US and Polish trial of Berubicin in adults with GBM during the second half of 2020."

https://www.globenewswire.com/news-release/2020/04/30/2025162/0/en/WPD-Pharmaceuticals-and-CNS-Pharmaceuticals-Identify-Leading-Polish-Medical-Institutions-for-Berubicin-Phase-2-Clinical-Trial.html

135